Skip to main content
CBUS
NASDAQ Life Sciences

Cibus Narrows Q3 Loss but Cash Runs to Early Q1 2027

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$1.08
Mkt Cap
$83.308M
52W Low
$1.07
52W High
$4.191
52W Position info
0.9% above low
Off High info
74% below high
Rel. Volume info
1.6× avg
Market data snapshot near publication time

CBUS is trading near its 52-week low of $1.07 (0.9% above the low).

Summary

Cibus posted a Q3 net loss of $21.9 million, or $0.29 per share, versus $24.3 million a year ago, as R&D spending fell to $7.9 million from $10.8 million on lower headcount and facility closures. The problem is the balance sheet: cash stood at just $10.7 million on September 30, and management says that funds operations only into early Q1 2027 without new financing. Nine-month operating cash burn was $30.2 million, about 19% better than last year, and the company still targets roughly $35 million annualized net cash use exiting 2026. On the commercial side, Rice herbicide-tolerance traits are now being tested in customer Interoc's own varieties in Ecuador with results due Q1 2027, and Cibus started manufacturing its first two biofragrance products, a program it pegs at up to about $100 million in peak annual revenue. With the stock near its 52-week low and a going-concern overhang, the near-term story is funding, not pipeline progress. Watch for a definitive Interoc commercialization agreement and any capital raise, given the $200 million shelf and $50 million ATM already in place.

At the time of this announcement, CBUS was trading at $1.08 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $83.3M. The 52-week trading range was $1.07 to $4.19. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

CBUS - Latest Insights

CBUS
Nov 12, 2026, 4:34 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.08
Real-time Price: $1.08 info
Change: $0 (0%) info
Market Cap: $83.308M info
CBUS
Aug 13, 2026, 4:32 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.62
Real-time Price: $1.08 info
Change: -$0.5363 (-33%) info
Market Cap: $83.308M info
CBUS
Aug 13, 2026, 4:14 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.68
Real-time Price: $1.08 info
Change: -$0.600 (-36%) info
Market Cap: $83.308M info
CBUS
Jun 17, 2026, 8:05 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $1.32
Real-time Price: $1.08 info
Change: -$0.240 (-18%) info
Market Cap: $83.308M info
CBUS
Jun 09, 2026, 8:19 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.23
Real-time Price: $1.08 info
Change: -$0.150 (-12%) info
Market Cap: $83.308M info